American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Novo trak ellers det længste strå i 2024, hvor de afsluttede året med at sidde på 59 procent af det amerikanske ...
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.